Tratamiento de insuficiencia cardiaca crónica en presencia de comorbilidades

Abstract

Heart failure is a clinical syndrome characterized by a failure in the pump function of the heart, and is due at the expense of different cardiovascular risk factors and different comorbidities that influence the incidence of this clinical entity. Adult men over the age of 65 and older represent the greatest morbidity in heart failure, in turn this pathological condition is a public health disease and high socioeconomic impact. In this work it aimed to determine the timely treatment of chronic heart failure in the presence of comorbidities for reducing the risk of hospitalization and mortality. A qualitative methodology of descriptive and explanatory type was used, through the collection of up-to-date scientific information, of quality and high impact on health and scientific dissemination, which determines the timely treatment of chronic heart failure in the presence of comorbidities, applied to a clinical case. Proper therapeutic management of heart failure involves both non-pharmacological treatment based on diet, physical exercise and weight reduction, as well as appropriate pharmacological treatment based on drugs conducive to this condition as angiotensin-converting enzyme inhibitors, aldosterone receptor antagonists, beta blockers and diuretics are critical and have been shown to improve the living conditions of this population , in addition to performing an integrated treatment of the patient's comorbidities in an appropriate way.